biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by rustycaton Aug 24, 2017 2:56pm

132 Views

Post# 26618319

RE:Nice jump today!

On the plus side, the stock has traded in excess of 9k shares in the US. I wonder if this is due to whispers in the Purdue ranks. On the negative side, vol. is nonsignificant in both Markets and with the 5.8 million shares hanging around waiting to look for the opportunity to make money, I'd not get too excited until there is a STATED reason for excitement.

Bullboard Posts

Rich TV Live’s Stocks to Watch this week (Nov. 15, 2024)